PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.95%
Both yoy net incomes decline, with MRVL at -82.75%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-4.60%
Both reduce yoy D&A, with MRVL at -1.25%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-52.94%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
24.14%
SBC growth while MRVL is negative at -12.49%. John Neff would see competitor possibly controlling share issuance more tightly.
-206.15%
Both reduce yoy usage, with MRVL at -547.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-131.45%
AR is negative yoy while MRVL is 5.53%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-242.50%
Both reduce yoy inventory, with MRVL at -164.91%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-5300.00%
Negative yoy AP while MRVL is 128.16%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-479.49%
Both reduce yoy usage, with MRVL at -258.88%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
129.30%
Well above MRVL's 153.91%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-54.34%
Both yoy CFO lines are negative, with MRVL at -62.12%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
24.39%
Some CapEx rise while MRVL is negative at -29.74%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Both yoy lines negative, with MRVL at -72.72%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
81.02%
Some yoy expansion while MRVL is negative at -14.21%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
105.95%
We have some liquidation growth while MRVL is negative at -0.29%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
94.83%
Growth well above MRVL's 72.72%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
184.89%
We have mild expansions while MRVL is negative at -48.56%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-38.18%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-0.48%
We cut yoy buybacks while MRVL is 4.32%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.